To explore the clinical value of a new tactic with novel dodecafluoropentane (C₅F₁₂, DDFP) acoustic vaporizable nano-droplets for the therapy of coronary micro-circulation thrombolysis.

Group A was poly butylene succinate buffer solution as blank control; group B was SonoVue microbubbles; group C was DDFP acoustic vaporizable nano-droplets, which were produced with emulsion process by ultrasonic oscillation instrument and rotary evaporator. The size of the nano-droplet was tested by Malvern laser particle size detector and observed with fluorescence microscope. The stability and efficiency of cavitation effect of group C for thrombolysis were tested in an in-vitro artificial vascular system with arterial thrombus model, comparing with group A and B. Weights and pathological sections of the inserted thrombus before and after the thrombolysis in these groups were compared for the thrombolytic efficiency.

The average size of DDFP nano-droplets were (424.7±30.2)nm. More than 75% of the nano-droplets were ranged from 300-750 nm. The fluorescence microscope showed the DDFP nano-droplets were uniformed round-shaped and stable-structured with favorable dispersity; the nano-droplets had gradually turned into over 3 μm microbubbles under ultrasound irradiation. The thrombus weight loss after thrombolysis in group C [(199.0±35.8)mg, (32.1±4.4)%] was significantly larger than those in group A [(30.2±17.8)mg, (5.0±2.4)%] and B [ (72.6±20.7)mg, (12.7±2.8)%] (all P<0.01).

DDFP vaporizable nano-droplets with ultrasound irradiation is effective for thrombus elimination in coronary micro-circulation through lasting and stable cavitation effect.

Sonication; Vaporizable nano-droplet; Thromboembolism; Thrombolytic therapy